As a caregiver, I can recall some moments when the kindest thing I could have done felt brutal. Sometimes, when I reflect on the…
Myeloma
Add-on treatment with mezigdomide significantly delayed cancer progression among people with hard-to-treat myeloma in a Phase 3 clinical trial, according to interim data announced…
There’s a nylon duffel bag that remains by my front door — but it isn’t for the gym, grocery shopping, or anything like that. The…
The U.S. Food and Drug Administration (FDA) has approved the combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) for treating certain…
Is this morbid? I have a new habit after my multiple myeloma diagnosis. When I see a headline that says someone famous has cancer,…
We are told different stories about what is involved in caregiving and who a caregiver is supposed to be. These tales are usually pristine and…
March is Myeloma Action Month (MAM), and organizations around the world are participating to support patients, families, and caregivers who live with myeloma. This year,…
I’ve recently discovered that being a caregiver has much in common with mathematics. I’m not referring to the difficulties and complexities of that subject, but…
The U.S. Food and Drug Administration (FDA) is reviewing an application from Bristol Myers Squibb (BMS) seeking approval of its investigational oral therapy iberdomide…
The entrance to my local supermarket becomes a danger zone at this time of year. The danger is deceptive: girls dressed in brown and green,…
Recent Posts
- Early ovarian cancer trial seeking participants to test higher therapy dose
- As a caregiver, I’ve learned to read my mum’s daily forecast
- Short radiation course may ease painful myeloma bone lesions
- Nearly 70% of those given approved myeloma therapy alive 5 years later
- Latest AACR progress report on myeloma is a superpower of good news